Taken together, our observations improve our understanding of GFI1 function, identified a novel role for GFI1 variants in heme biosynthesis and established GFI1 variants as biomarkers in AML therapeutic strategies. The gene discussed is GFI1; the disease is acute myeloid leukemia.